Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B N Yamaja Setty

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Laboratory and Clinical Medicine|March 29, 2002
Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B4 to disease pathophysiologyB N Yamaja Setty, Marie J Stuart
Translational Research : the Journal of Laboratory and Clinical Medicine|October 23, 2008
Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domainSuhita Gayen Betal, B N Yamaja Setty
Blood|October 4, 2007
Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytesB N Yamaja Setty, Suhita Gayen Betal
Blood|February 28, 2002
Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesionB N Yamaja Setty, Surekha Kulkarni, Marie J Stuart
Biochemical and Biophysical Research Communications|October 29, 1987
13-Hydroxyoctadeca-9,11-dienoic acid (13-HODE) inhibits thromboxane A2 synthesis, and stimulates 12-HETE production in human plateletsB N Yamaja Setty, M Berger, M J Stuart
Biochemical and Biophysical Research Communications|November 30, 1984
Kinetic analyses of the effects of hyperoxia and hypoxia on vascular cyclooxygenase activity in vitroB N Yamaja Setty, R W Walenga, M J Stuart
Lancet (London, England)|November 7, 2003
Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiologyB N Yamaja Setty, Marie J Stuart, Carlton Dampier, et al.
Journal of Pediatric Hematology/Oncology|December 14, 2004
Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlatesCarlton Dampier, B N Yamaja Setty, Barry Eggleston, et al.
British Journal of Haematology|February 25, 2012
Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysisB N Yamaja Setty, Nigel S Key, A Koneti Rao, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 13, 2019
Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemiaB N Yamaja Setty, Suhita Gayen Betal, Robin E Miller, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Laboratory and Clinical Medicine|March 29, 2002
Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B4 to disease pathophysiologyB N Yamaja Setty, Marie J Stuart
Translational Research : the Journal of Laboratory and Clinical Medicine|October 23, 2008
Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domainSuhita Gayen Betal, B N Yamaja Setty
Blood|October 4, 2007
Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytesB N Yamaja Setty, Suhita Gayen Betal
Blood|February 28, 2002
Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesionB N Yamaja Setty, Surekha Kulkarni, Marie J Stuart
Biochemical and Biophysical Research Communications|October 29, 1987
13-Hydroxyoctadeca-9,11-dienoic acid (13-HODE) inhibits thromboxane A2 synthesis, and stimulates 12-HETE production in human plateletsB N Yamaja Setty, M Berger, M J Stuart
Biochemical and Biophysical Research Communications|November 30, 1984
Kinetic analyses of the effects of hyperoxia and hypoxia on vascular cyclooxygenase activity in vitroB N Yamaja Setty, R W Walenga, M J Stuart
Lancet (London, England)|November 7, 2003
Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiologyB N Yamaja Setty, Marie J Stuart, Carlton Dampier, et al.
Journal of Pediatric Hematology/Oncology|December 14, 2004
Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlatesCarlton Dampier, B N Yamaja Setty, Barry Eggleston, et al.
British Journal of Haematology|February 25, 2012
Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysisB N Yamaja Setty, Nigel S Key, A Koneti Rao, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 13, 2019
Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemiaB N Yamaja Setty, Suhita Gayen Betal, Robin E Miller, et al.
Pageof 1